Keywords: gsk, treximet, receives, fda, approval, uk, drug

GSK's Treximet receives FDA approval

Article | 21 April 2008

Print This

UK drug major GlaxoSmithKline and US company Pozen's co-developed long-awaited migraine drug, Treximet, has finally received US Food and Drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in